Efficacy and safety of avacincaptad pegol in patients with geographic atrophy (GATHER2): 12-month results from a randomised, double-masked, phase 3 trialArshad M. Khanani, Francisco J. Rodríguez, Jordi Monés et al.|The Lancet|2023Cited by 343
Atherosclerosis and Microvascular Complications: Results From the Canadian Study of Longevity in Type 1 DiabetesJulie A. Lovshin, David Z.I. Cherney, Petter Bjornstad et al.|Diabetes Care|2018Cited by 60
Renin-angiotensin-aldosterone system activation in long-standing type 1 diabetesJulie A. Lovshin, David Z.I. Cherney, Geneviève Boulet et al.|JCI Insight|2018Cited by 55
Neuropathy and presence of emotional distress and depression in longstanding diabetes: Results from the Canadian study of longevity in type 1 diabetesJohnny-Wei Bai, Bruce A. Perkins, Leif E. Lovblom et al.|Journal of Diabetes and its Complications|2017Cited by 49
Adiposity Impacts Intrarenal Hemodynamic Function in Adults With Long-standing Type 1 Diabetes With and Without Diabetic Nephropathy: Results From the Canadian Study of Longevity in Type 1 DiabetesPetter Bjornstad, David Z.I. Cherney, Julie A. Lovshin et al.|Diabetes Care|2018Cited by 33